– UK, Weybridge – Haleon plc (LON: HLN / NYSE: HLN) announced the appointment of Alan Stewart and Nancy Avila to its Board as Independent Non-Executive Directors effective on 1 September 2024.
Alan Stewart will join the Audit & Risk, Environmental & Social Sustainability, Nominations & Governance, and Remuneration Committees. He will then succeed Deirdre Mahlan as the Chair of the Audit & Risk Committee on 1 October 2024.
Nancy Avila will join the Audit & Risk Committee.
“I would like to welcome Alan and Nancy to Haleon. Alan will bring a wealth of board, executive and leadership insights and Nancy will bring valuable technology, business transformation, and digital and cyber experience to support the Board’s discussions in these areas. I would like to thank Deirdre for her considerable contributions to the Board and for chairing the Audit & Risk Committee since Haleon’s listing in July 2022. We wish her all the best for the future.” said Board Chair, Sir Dave Lewis.
About Alan Stewart
Alan Stewart has significant corporate finance, accounting, and international experience from a wide range of consumer-related industries. He has extensive board and listed company experience. He is currently a Non-Executive Director on the boards of Diageo plc, where he chairs the Audit Committee and is a member of the Remuneration and Nomination Committees, and Burberry Group plc where he chairs the Audit Committee and is a member of the Nomination and Remuneration Committees. He was previously a Non-Executive Director and Chair of the Remuneration Committee of Reckitt Benckiser Group PLC. In his executive career, Alan was CFO of Tesco PLC from 2014 to 2021. Before joining Tesco, Alan Stewart was CFO of Marks & Spencer PLC. He is a Chartered Accountant. He was a founder member of the Accounting 4 Sustainability CFO network and is currently a member of Chapter Zero.
About Nancy Avila
Nancy Avila has spent the majority of her career in technology and business operations in healthcare, life sciences, industrial, and distribution across several Fortune 100 companies, including McKesson Corporation, where she was CITO, Johnson Controls Inc., and Abbott Laboratories Inc. Nancy has significant experience leading business transformations with technology, developing new digital channels for growth, modernizing operations and addressing regulatory, technology, cyber and financial risk. She is an independent Director of Comerica Incorporated and a member of the Enterprise Risk Committee.
About Haleon
Haleon is a global leader in consumer health, in delivering better everyday health to humanity. Haleon’s product portfolio spans five major categories – Oral Health, Pain Relief, Respiratory Health, Digestive Health and others, and Vitamins, Minerals, and Supplements. Its long-standing brands – such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, periodontal, and Centrum – are built on trusted science, innovation, and deep human understanding.
For more: https://www.haleon.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.